Prediction of lymph node metastasis and prognosis from the assay of the expression of proliferating cell nuclear antigen and DNA ploidy in gastric cancer

Oncology. 1994 May-Jun;51(3):251-7. doi: 10.1159/000227344.

Abstract

Cell proliferation of 174 specimens obtained from the primary gastric cancers using endoscopic biopsy was investigated by immunohistochemical analysis with the monoclonal antibody PC10, which recognizes a proliferating cell nuclear antigen (PCNA) in formalin-fixed and paraffin-embedded material. All the examined samples showed nuclear staining for PCNA in cancer cells. The investigation was to test the correlation between PCNA labeling and lymph node metastasis. DNA aneuploidy was often encountered in tumors with nodal involvement and lymphatic invasion. The logistic regression analysis identified PCNA labeling rates (LRs), tumor size, and macroscopic type as independent significant factors for lymph node metastasis. When the PCNA LRs and clinicopathologic parameters were entered into the Cox regression analysis, PCNA LRs and DNA ploidy emerged as independent significant prognostic factors. In addition, combination assay of PCNA LRs and DNA ploidy yielded a powerful prognostic indication for patients with gastric cancer.

Publication types

  • Comparative Study

MeSH terms

  • Bromodeoxyuridine / metabolism
  • Cell Division / physiology
  • DNA, Neoplasm / analysis
  • DNA, Neoplasm / genetics*
  • Humans
  • Immunohistochemistry
  • Lymphatic Metastasis / diagnosis*
  • Nuclear Proteins / analysis*
  • Nuclear Proteins / immunology
  • Ploidies*
  • Predictive Value of Tests
  • Prognosis
  • Proliferating Cell Nuclear Antigen
  • Stomach Neoplasms / chemistry
  • Stomach Neoplasms / genetics*
  • Stomach Neoplasms / pathology*

Substances

  • DNA, Neoplasm
  • Nuclear Proteins
  • Proliferating Cell Nuclear Antigen
  • Bromodeoxyuridine